Weihong Jiang, MD

Xiangya Hospital Central South University, United States

Presentation(s):

• CD20+FCRL4+B Cells Activate CD8+T Cells in an MHC-I Restricted Manner in Nasopharyngeal Carcinoma Anti-tumor Immunity

  Saturday, September 28, 2024
  9:36 AM – 9:42 AM EDT

  Disclosure information not submitted.

• The Clinical Efficacy and Safety of Highly Selective Vidian-Branch Neurectomy in Intractable Allergic Rhinitis

  Sunday, September 29, 2024
  9:42 AM – 9:48 AM EDT

  Disclosure information not submitted.

• Elevated BMI Aggravates Histopathological Changes and the Risk of Postoperative Recurrence of CRSwNP

  Sunday, September 29, 2024
  9:48 AM – 9:54 AM EDT

  Disclosure information not submitted.